| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | insulin aspart (Fiasp®) |
| Formulation | 100 units/ml subcutaneous injection |
| Reference number | 2787 |
| Indication | Treatment of diabetes mellitus in adults |
| Company | Novo Nordisk Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 30/11/2016 |